(Last updated : 2020-01-30 17:46:27)
  堅田 洋佑
   Department     ,
   Position  
■ Journal
1. 2018/03 Clinical outcomes of women with ovarian metastases of colorectal cancer treated with oophorectomy with respect to their somatic mutation profiles.  Link
2. 2016/05 A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients with Incurable Pancreatic Cancer. 
3. 2015/09 Current Cancer Immunotherapy Using Activated Lymphocytes -Do Lymphocytes Actually Recognize Cancer Cells? 
■ Presentation
1. 2019/07/05 Poor prognosis of hypermutant colorectal cancer with KRAS mutations: A retrospective analysis of 1,052 Japanese colorectal cancer patients without treatment of immuno-checkpoint inhibitors   Link
2. 2019/07/04 Relationship between peripheral neuropathy and effectiveness in second-line chemotherapy for unresectable advanced gastric cancer: a prospective, observational, multicenter study protocol  
3. 2018/11/24 Efficacy of Ramucirumab in combination with second-line or salvage-line FOLFIRI in patients with metastatic colorectal cancer.  
4. 2018/11/24 Incidence of catheter-related thrombosis in patients with long-term indwelling central venous catheter who received chemotherapies for unresectable advanced digestive cancers  
5. 2018/11/10 Clinico-pathological features of hypermutant colorectal cancers analyzed over 1000 colorectal cancer  
Display all(11)